DVL3 and non-small cell lung carcinoma: Zhao et al. [16] found positive expression of DVL1 and DVL3 in 45.1% and 48% of non small cell lung cancer (NSCLC) (squamous cell carcinoma (SCC) and adenocarcinoma).